Product Name: p38d (324-338)
Product Number: PE-01AYH80
Size: 200 µg      Price:38.00
1 mg      $US77.00
5 mg      166.00
Peptide Name: p38d (324-338)

Product Use: Services as a blocking peptide for use with the p38d-2 rabbit polyclonal antibody (Cat. No.: AB-NK121-3) that is also available from Kinexus. The peptide sequence is located in the post-kinase last alpha-chain.

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: Homo sapiens

Peptide Sequence: CFDDSLEHEKLTVDEW

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: Amide

Peptide Molecular Mass Calculated: 1965.1 Da

Peptide Purity Percent after Synthesis and Purification: >80

Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Related Product 1: p38d pan-specific antibody (Cat. No.: AB-NK121-3)

Scientific Background: p38d (MAPK13) is a protein-serine/threonine kinase that is essential for MAP kinase signalling. p38d signalling can be induced via physical stress or proinflammatory cytokines resulting in the activation of the transcription factors ELK1 and ATF2. Cellular stress or pro-inflammatory cytokines can induce p38d-mediated activity. p38d is activated by cytokines and stresses and affects proliferation, differentiation, transcription regulation, translation regulation, cytoskeleton regulation, insulin secretion, cell survival and development. p38d can be a positive or negative regulator of the above processes depending on the cell context. Increased expression of p38d has been associated with increases proliferation and metastatic progression. It is also hypermethylated in some cancer cell lines. The rare liver cancer Cholangiocarcinoma (CCA, CC) has been noted to have a significant up-regulation of p38d compared to normal bile duct tissue. Insulin secretion and pancreatic beta cell survival can be regulated by p38d. The phosphotransferase activity of p38d can be abrogated with a T180A or a Y182A mutation.